Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Sorrento TherapeuticsPassage BioNanoString TechnologiesBeam TherapeuticsBAVARIAN NORDIC/S
Price Information
Current Price$6.85$26.15$35.03$28.87$8.60
52 Week RangeBuyBuyBuyBuyN/A
Beat the Market™ Rank
Overall Score1.
Analysis Score3.
Community Score3.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$23.00$28.50$35.67N/AN/A
% Upside from Price Target235.77% upside8.99% upside1.82% upsideN/AN/A
Trade Information
Market Cap$1.44 billion$1.19 billion$1.32 billion$1.49 billion$833.60 million
Average Volume28,338,672336,452615,904361,685237
Sales & Book Value
Annual Revenue$31.43 millionN/A$125.57 million$20,000.00$99.33 million
Price / Sales45.70N/A10.5374,325.828.39
Price / CashN/AN/AN/AN/AN/A
Book Value$0.20 per shareN/A$2.91 per shareN/A$2.88 per share
Price / Book34.25N/A12.042.99
Net Income$-292,070,000.00N/A$-40,700,000.00N/A$-51,980,000.00
Trailing P/E RatioN/A0.00N/AN/A35.83
Forward P/E RatioN/AN/AN/AN/A43.00
Net Margins-754.90%N/A-46.13%N/A29.20%
Return on Equity (ROE)-576.10%N/A-73.44%N/A9.66%
Return on Assets (ROA)-37.33%N/A-27.10%N/A4.92%
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio4.59%N/A1.43%N/A0.09%
Current Ratio0.55%N/A8.95%N/A3.70%
Quick Ratio0.52%N/A8.32%N/A3.44%
Ownership Information
Institutional Ownership Percentage16.18%64.24%N/A50.90%N/A
Insider Ownership Percentage4.80%N/A5.10%0.74%N/A
Shares Outstanding209.69 million45.35 million37.73 million51.49 million96.93 million
Next Earnings Date8/14/2020 (Estimated)8/10/2020 (Estimated)7/29/2020 (Estimated)8/11/2020 (Estimated)8/20/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.